Recent Articles

• 
  Medical / Research

  KAIST Team Identifies Protein That Slows Aging

  Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have confirmed that FARSA interacts with enzymes that unwind RNA structures to prevent the accumulation of mitochondria-derived dsRNA that has leaked into the cytoplasm, thereby blocking immune activation and delaying agin

  2026.05.27
• 
  Pharmaceutical R&D

  Health Capsule: Ginkgo Extract Shown to Inhibit Beta-Amyloid

  ■ Ginkgo biloba extract found to have ‘beta-amyloid aggregation inhibition’ effect Ginkgo biloba extract has been confirmed as a potential inhibitor of beta-amyloid aggregation, which is known as a major cause of Alzheimer’s dementia.Professor Yang Young-soon of the Department of Neurology at Soonch

  2026.05.27
• 
  Medical / Research

  KAIST Identifies Protein That Slows Cellular Aging

  Illustration explaining the role of FARSA in maintaining the immunity-longevity balance through dsRNA regulation (provided by KAIST research fellow Son Juyoun) / News1 Domestic researchers have confirmed that when the internal cellular “immune alarm” that is triggered to respond to invading external

  2026.05.26
• 
  Bioprocessing / CDMO

  Noroo Holdings Wins State Project for 3-HP Scale-Up

  Noroo Holdings was recently selected as the final implementing organization for the project “Technology Development for Raw Material Production and High Value-Added Products to Revitalize the Bio-Derived Polymer Market,” supervised by the Korea Evaluation Institute of Industrial Technology (KEIT). P

  2026.05.26
• 
  AI Healthcare

  Celltrion Accelerates AI Shift From R&D to Automation

  Panoramic view of Celltrion headquarters. Provided by Celltrion Celltrion announced on the 26th that it will promote AI Transformation (AX) focused on three core business areas: new drug development, manufacturing, and office work. The company plans to reduce repetitive tasks and enhance the efficie

  2026.05.26
• 
  Global Business

  K-Bio Materials ‘First Mover’ Targets Global Market

  Exosome medium supply contract signing ceremony with China’s Xiangya Bio held at Excel Therapeutics’ headquarters in Gangnam-gu, Seoul, on March 24. Courtesy of Excel Therapeutics CEO Lee Eui-il The cell and gene therapy (CGT) market is projected to expand to approximately KRW 103 trillion by 2030,

  2026.05.26
• 
  Clinical Trial

  Eli Lilly’s Next-Gen Obesity Drug Tops Mounjaro

  Obesity treatment market size US pharmaceutical company Eli Lilly, which developed the obesity treatment “Mounjaro,” announced that its next-generation obesity treatment candidate “retatrutide” demonstrated approximately 28% weight loss in a Phase 3 clinical trial. This is a level of weight reductio

  2026.05.22
• 
  Public Health

  Patients Quit Cholesterol Drugs Following YouTube Claims

  In a YouTube video that has garnered more than 1.3 million views, a private practitioner who introduced himself as a functional medicine doctor claimed that “the side effects of dyslipidemia drugs are too great” and argued that “if total cholesterol levels fall after taking dyslipidemia drugs, the r

  2026.05.22
• 
  Medical / Research

  Protein Deficit Prompts Gut to Signal Brain for Amino Acids

  ⓒNewsis It has been discovered that when proteins in the body become deficient, the intestine regulates neurons in the brain to induce behavior that prioritizes the intake of essential amino acids, which are nutrients the body cannot synthesize on its own. The findings are drawing attention as a pot

  2026.05.22
• 
  Biotech

  CKD Backs Multi-Target Protein Tech, Awards Apellos Golden Ticket

  (From right) Kim Jae-soon, Vice President and Head of New Drug Business Development at Chong Kun Dang, Golden Ticket judge Dr. Debra Peattie, Luciano Santollani, CTO of Arpelos Biosciences, Kim Sun-hong, Head of Research Planning at Chong Kun Dang, and Kim Ho-won, Head of CKD USA, take a commemorati

  2026.05.21